First U.S. Center Treats Patient with the New TomoHDA™ System
New Tulsa Cancer Institute Offers Accuray’s Latest Cancer Fighting Technology SUNNYVALE, Calif., June 25, 2013 – Accuray Incorporated (Nasdaq: ARAY), announced today that the Tulsa Cancer Institute is the first U.S. center to treat a patient with Accuray’s TomoHDA™ System, the latest and most advanced innovation in the TomoTherapy® product lineage designed to treat the full spectrum of cancer […]